Medium impactPrior AuthMedicare Advantage
Humana: Eprontia (topiramate) oral solution prior authorization - Medicare Advantage (New)
Payer's title: Eprontia® (topiramate) oral solution (New)
Effective dateJan 1, 2026
Found onJun 24, 2026
Humana · The summary is ours. The payer's notice is the final word.View original ↗
Summary
Humana Medicare Advantage now requires prior authorization for Eprontia (topiramate) oral solution effective January 1, 2026. This affects patients with epilepsy (age 2+) and migraine prevention (age 12+), with specific criteria including previous trial or intolerance to immediate-release topiramate tablets/capsules.
PolicyChanges checks Humana and other payers every day and shows what to do before a change takes effect.
See every Humana changeWhat to do
Action · 3 steps
- Before January 1, 2026: Billing team must update prior authorization requirements for Eprontia (topiramate) oral solution prescriptions for Humana Medicare Advantage patients.Passed
- Providers must document patient age requirements (2+ for epilepsy, 12+ for migraine), previous treatment history with immediate-release topiramate, and additional step therapy requirements for migraine patients.
- Claims without prior authorization will be denied.
Related changes
See all Humana changes →Eprontia® (topiramate) oral solution (New)Published Jan 2026: Humana's Medicare Advantage policy for Eprontia (topiramate) oral solution sets prior authorization criteria for migraine prevention, epilepsy adjunct therapy,Effective Jan 1, 2026 · Medicare AdvantageMediumEprontia® (topiramate) oral solution (New)Humana Medicare Advantage has implemented a new prior authorization policy for Eprontia (topiramate) oral solution effective January 1, 2026. Prior authorization is required for…Effective Jan 1, 2026 · Medicare AdvantageMedium